Results from the first completed clinical trial facilitated and organized by DKMS, the world’s largest stem cell donor center, suggest that adult patients who have relapsed or refractory acute myeloid leukemia should receive stem cell transplantation as soon as possible.
Zachary SteinhartMaxwell FoiseyDebolina GangulySean Yamada-HunterThe Parker Institute for Cancer Immunotherapy, a collaborative consortium of the world’s leading immuno-oncology experts, named its 2024 class of Early Career Researcher awardees.
